4//SEC Filing
HANSEN JOHN DAVID 4
Accession 0001415889-18-000082
CIK 0001109196other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 8:00 PM ET
Size
5.7 KB
Accession
0001415889-18-000082
Insider Transaction Report
Form 4
HANSEN JOHN DAVID
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2018-01-16$0.92/sh−59,263$54,522→ 536,730 total
Footnotes (2)
- [F1]Represents a portion of the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs listed in Table II of the reporting person. This sale is mandated by the Issuer's election under the equity incentive plan to require satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.86 to $1.00 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
MABVAX THERAPEUTICS HOLDINGS, INC.
CIK 0001109196
Entity typeother
Related Parties
1- filerCIK 0001186123
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 8:00 PM ET
- Size
- 5.7 KB